Please login to the form below

Not currently logged in
Email:
Password:

Ferring Pharmaceuticals promotes Aaron Graff

He takes up role as chief commercial officer and joins its executive board

Aaron GraffSwiss biopharmaceutical company Ferring Pharmaceuticals has promoted Aaron Graff to chief commercial officer and executive vice president.

He was previously CEO of Ferring’s US operations and in his new role he will also sit on the Saint-Prex-based firm’s executive board.

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen.

After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

He was then made senior VP, Asia region and global marketing, and since 2010 has led Ferring’s stateside operations from its US headquarters in New Jersey, first as chief operating officer and since 2016 as CEO.

Michel Pettigrew, president of Ferring Pharmaceuticals’ executive board and chief operating officer, said: “Under Aaron’s leadership in the United States, our US business grew at double-digit rates. His broad, global professional experience and track record make him uniquely qualified for this important role.”

Prior to joining Ferring, Graff worked at Bristol-Myers Squibb for over 17 years in a variety of sales, marketing and commercial operations management positions.

2nd June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

WHITE PAPER: The increasing importance of clinical trial marketing advertising in patient recruitment
Learn why advertising is more important than ever in clinical studies...
The 'winner takes all' pricing game
Tendering has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s....
Early diagnosis underpins NHS cancer strategy
Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan...

Infographics